4.8 Article

Income and patient-reported outcomes (PROs) after primary total knee arthroplasty

Journal

BMC MEDICINE
Volume 11, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1741-7015-11-62

Keywords

arthroplasty; income; joint replacement; patient-reported outcomes; risk factor; total knee replacement

Funding

  1. Takeda
  2. Savient
  3. URL pharmaceuticals
  4. Regeneron
  5. Allergan
  6. Ardea
  7. Novartis
  8. Zimmer
  9. Orthosonic
  10. Osteotech
  11. Pipeline Biomedical
  12. DePuy
  13. Stryker
  14. Biomet
  15. Mayo Clinic Orthopedic Surgery research funds
  16. Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs)
  17. National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)
  18. National Institute of Aging (NIA)
  19. National Cancer Institute (NCI)

Ask authors/readers for more resources

Background: To assess whether income is associated with patient-reported outcomes (PROs) after primary total knee arthroplasty (TKA). Methods: We used prospectively collected data from the Mayo Clinic Total Joint Registry to assess the association of income with index knee functional improvement, moderate to severe pain and moderate to severe activity limitation at 2-year and 5-year follow-up after primary TKA using multivariable-adjusted logistic regression analyses. Results: There were 7, 139 primary TKAs at 2 years and 4, 234 at 5 years. In multivariable-adjusted analyses, at 2-year follow-up, compared to income > US$45, 000, lower incomes of <= US$35, 000 and > US$35, 000 to 45, 000 were associated (1) significantly with moderate to severe pain with an odds ratio (OR) 0.61 (95% CI 0.40 to 0.94) (P = 0.02) and 0.68 (95% CI 0.49 to 0.94) (P = 0.02); and (2) trended towards significance for moderate to severe activity limitation with OR 0.78 (95% CI 0.60 to 1.02) (P = 0.07) and no significant association with OR 0.96 (95% CI 0.78 to 1.20) (P = 0.75), respectively. At 5 years, odds were not statistically significantly different by income, although numerically they favored lower income. In multivariable-adjusted analyses, overall improvement in knee function was rated as 'better' slightly more often at 2 years by patients with income in the <= US$35, 000 range compared to patients with income > US$45, 000, with an OR 1.9 (95% CI 1.0 to 3.6) (P = 0.06). Conclusions: We found that patients with lower income had better pain outcomes compared to patients with higher income. There was more improvement in knee function, and a trend towards less overall activity limitation after primary TKA in lower income patients compared to those with higher incomes. Insights into mediators of these relationships need to be investigated to understand how income influences outcomes after TKA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available